CompletedPhase 4

Management of Pain in Lumbar Arthrodesis

Spain128 participantsStarted 2013-07-04

Plain-language summary

KETAMINE AND DEXAMETASONE IN THE MANAGEMENT OF PAIN IN LUMBAR ARTHRODESISPhase IV prospective randomized controlled single-center clinical trial to determine the effect of intravenous ketamine and dexamethasone administration perioperatively in patients undergoing lumbar arthrodesis.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Male or female * Age\> 18 years * ASA I-III. * Lumbar arthrodesis. * Patients who have signed the preoperative informed consent for participation in the study. Exclusion Criteria: * Unstable coronary heart disease * Glaucoma * History of allergy to ketamine, dexamethasone, or morphic chloride * Dementia or inability to understand IC and study * Pluricomplicated diabetes mellitus difficult to control * Patients who have taken an experimental drug 30 days before the start of the study or who are included in any type of study of an experimental drug

What they're measuring

Efficacy of Morphic Chloride (PCA) to treat pain during the post-operative period. Consumption of morphics will be evaluated

Timeframe: 4 hours post operative

Trial details

NCT IDNCT04751175

SponsorInstitut d'Investigació Biomèdica de Girona Dr. Josep Trueta

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-07-31

View on ClinicalTrials.gov More Pain, Postoperative trials